P, F., S, K., S, B., C, G., A, N., S, W., . . . M, O. (2014). Efficacy and Safety of Darunavir/Ritonavir at 48 Weeks in Treatment-naive, HIV-1-infected Adolescents Results From a Phase 2 Open-label Trial (DIONE).
Chicago Style CitationP, Flynn, et al. Efficacy and Safety of Darunavir/Ritonavir At 48 Weeks in Treatment-naive, HIV-1-infected Adolescents Results From a Phase 2 Open-label Trial (DIONE). 2014.
MLA CitationP, Flynn, et al. Efficacy and Safety of Darunavir/Ritonavir At 48 Weeks in Treatment-naive, HIV-1-infected Adolescents Results From a Phase 2 Open-label Trial (DIONE). 2014.
Warning: These citations may not always be 100% accurate.